CD4 and pulmonary fibrosis: Antibody-mediated inhibition of the accumulation of CD3+ lymphocytes or depletion of CD4 and CD8 T lymphocytes also reduced fibrosis levels in the murine model of pulmonary fibrosis induced by the radiomimetic and DNA-damaging drug bleomycin (BLM) (44, 45).